TLPH

TALPHERA, INC.

Healthcare · Drug Manufacturers - Specialty & Generic

$277.28 sample

+0.34 (+0.12%) 1D

Market cap

$1.04T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-21

Alerts

8

Price$277.28 +2.53% 3M daily closessample

280.58263.01

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider buy: 10% owner
Sep 29INSInsider sell: General Counsel
Sep 21SEC10-Q filed
Sep 14SEC8-K filed: material event
Sep 09INSInsider sell: Chief Executive Officer
Sep 01INSInsider buy: EVP, Operations
Aug 24SEC10-Q filed
Aug 13INSInsider sell: Chief Financial Officer

Sign up to see the real TLPH record →

Company facts

SEC EDGAR registration

Name: TALPHERA, INC.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +45sample, -100 to +100
Reporting currency: USD

Who is positioning in TLPH

sample

Insiders: 25 insider transactions over 90 days, net selling, $890.1M
Congress: 1 members traded over 90 days
Institutions · 13F: 30 funds hold $7.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$69.9B +18.2% y/y

Q4 2024Q3 2026

Inventory$40.4B +12.2% y/y

Q4 2024Q3 2026

Accounts receivable$31.9B +14.9% y/y

Q4 2024Q3 2026

Total debt$80.8B +6.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.02T +13.8% 3M
Sample peer B: $1.02T -9.4% 3M
Sample peer C: $1.00T +10.9% 3M
Sample peer D: $911.7B +6.4% 3M
Sample peer E: $646.2B +15.1% 3M